Pfizer is already laying the groundwork for what the pharmaceutical behemoth will look like when revenue from its outsized COVID-19 vaccine and treatment franchise begins to wane.
Pfizer PFE, +0.75% is already laying the groundwork for what the pharmaceutical behemoth will look like when revenue from its outsized COVID-19 vaccine and treatment franchise begins to wane.
“People are tired after three years of living very different, difficult lives,” Pfizer CEO Albert Bourla told MarketWatch. “So it’s clear that we will start seeing more and more waves. When people are wearing masks, when they are not having to provide guarantees that they are vaccinated or not, there will be waves. I don’t know if that will happen in the fall or it will happen in a different time in the U.S. because we have been surprised. But it will happen.
Moderna’s MRNA, +5.81% leadership has instead predicted that the bulk of its COVID-19 vaccine sales will occur in the second half of the year, timed to a fall booster campaign in the Western Hemisphere. “We continue to expect many more transactions from Pfizer over the next couple of years as management works to boost their pipeline and product portfolio,” Mizuho Securities analyst Vamil Divan told investors.“We are sourcing innovation also from the external and then we develop it internally,” Bourla said. “We are strong believers that the company that would become the partner of choice for biotech is the company that would give the next breakthroughs.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Q1 profit, revenue soar on COVID-19 vaccine salesCOVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street’s first-quarter expectations, as the drugmaker’s profit grew 61%.
Read more »
Pfizer Sales Soar on Covid-19 Vaccine SalesPfizer logged $25.7 billion in sales in the first-quarter, driven by sales of vaccine Comirnaty and Paxlovid, a pill aimed at reducing severe outcomes from Covid-19
Read more »
Covid-19 news: Cognitive impairment equivalent to 20 years of ageingToday’s covid-19 news: · Covid-19 hospitalisation equivalent to 20 years of ageing for the brain · Proteins responsible for covid-19-related condition in children identified · Covid-19 may worsen asthma in children
Read more »
What happens if I get COVID-19 while traveling?COVID-19 rules for travelers will vary depending on the destination. But testing positive for the virus could result in an unexpected change in plans, such as being required to stay isolated in a hoteI.
Read more »
Here’s why people with allergic asthma are at lower COVID-19 riskA protein called IL-13 mounts defenses that include virus-trapping mucus and armor that shields airway cells from infection.
Read more »
LA County health officials urge workplace safety as COVID-19 spread continuesHealth officials have been reporting elevated daily case numbers in recent weeks, attributable largely to the BA.2 subvariant of the virus. An offshoot of that variant -- known as BA.2.12.1 -- has also begun spreading locally, and health officials said it is believed to be 20% to 30% more infectious than BA.2.
Read more »